Skip to main content
. 2022 Nov 29;9:1034288. doi: 10.3389/fmed.2022.1034288

TABLE 2.

Distribution of blood parameters in patients stratified according to their World Health Organization (WHO) score at baseline.

WHO score ≤5 (n = 68; 75.6%) WHO score >5 (n = 22; 24.4%) P-value
Hb g/dL 12.7 + −2.1 (7.7–18.1) 12.6 + −2.5 (7.6–16.1) 0,839
WBC (cells/μl) 6,565 (4,660; 9212.5) (2,380–17,090) 7,765(5682.5; 10147.5) (4210–21,150) 0,131
Neutrophils (N/mmc) 5,525 (3,545; 7,735) (1,000–13,600) 6,200 (4,385; 8007.5) (3,680–19,200) 0,064
Lymphocytes (N/mmc) 845 (602.5; 1267.5) (260–2,970) 635 (465; 1037.5) (270–3,350) 0,069
Platelets (cell/μL) 225,000 (185,500; 282,000) (55,000–363,000) 234,000 (134,750; 295,250) (31,000–607,000) 0,974
Fibrinogen (mg/dl) 581.7 + −173.2 (283–1,000) 563.2 + −187.2 (260–1,000) 0,685
INR 1.1 (1.04; 1.22) (0.8–3.84) 1.1 (1.03; 1.19) (0.8–1.33) 0,622
D-Dimer (mg/l) 1.02 (0.56; 1.69) (0.04–18.99) 0.94 (0.43; 2.38) (0.18–25.56) 0,794
Albumin (g/dl) 3.5 + −0.5 (2.6–4.5) 3.6 + −0.5 (2.5–5) 0,562
Total bilirubin mg/dl 0.65 (0.45; 0.85) (0.21–5.09) 0.74 (0.5; 1.06) (0.26–1.54) 0,289
Direct bilirubin mg/dl 0.29 + −0.13 (0.1–0.76) 0.34 + −0.17 (0.1–0.69) 0,255
Ferritin (ng/ml) 533.5 (267.8; 744.5) (40–2,000) 488 (149; 820) (39–2,000) 0,816
AST U/L 25 (20; 33.5) (9–141) 29 (23.5; 35.5) (8–176) 0,135
ALT U/L 27 (19; 42) (7–177) 35 (21.5; 55) (9–474) 0,318
LDH U/L 289 (218; 383) (111–741) 373 (281.8; 465) (193–670) 0,013
hsCRP mg/L 9.3 (3.4; 33.8) (0.3–132.6) 15.8 (9; 44.5) (1.3–222.5) 0,039
IL-6 (pg/ml) 13.2 (7.2; 28.5) (2.3–63.4) 19.6 (6.3; 59.9) (3.5–258) 0,276

Data are expressed as mean ± standard deviation (range); median (25th; 75th percentile) (range) or absolute frequency (percentage). Hb, haemoglobin; WBC, white blood cells; INR, international normalized ratio; AST, aspartate transaminase; ALT, alanine transaminase; LDH, Lactate dehydrogenase; hsCRP, high sensitive C-reactive protein; IL-6, interleukin-6. Bold values indicate the strong correlation.